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ABSTRACT
An Evaluation of the Effect of an Educational Intervention at a Nurse-Run Clinic for
Women at Increased Risk for Breast Cancer on Anxiety, Depression, and Cancer Worry
Lisa Muto
Many women have risk factors that can increase their risk for developing breast cancer. These
women may benefit from recommendations based on their personal and family history. Women
at increased risk may experience higher levels of anxiety, depression, or cancer worry than
women who are at average or only slightly increased risk. By providing these women with an
accurate risk assessment, these factors may be decreased. The purpose of this project was to
evaluate the effect of a nurse-run clinic for women at increased risk for breast cancer on anxiety,
depression, and cancer worry.
A pre-test/post-test longitudinal design was used with a convenience sample of women at
increased risk for breast cancer. Participants completed a Modified Ways of Coping Scale, the
State portion of the State Trait Anxiety Inventory, the Brief Zung Self Rating Depression Scale,
and Lerman’s Breast Cancer Worry Scale prior to their appointment. Two weeks after the
appointment, participants were asked to complete the anxiety, depression and cancer worry tools
again by mail. Demographic data was also collected.
The visits were tailored based on the coping questionnaire. Results were marginally significant
for a decrease in anxiety. Results were non-significant for depression and cancer worry. Means
for all variables decreased. Recommendations include continuing to assess anxiety, depression,
and cancer worry at the high-risk clinic at ECCC.
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Chapter I
Introduction
Background and Significance
Breast cancer is a major problem worldwide (American Cancer Society [ACS], 2009).
It is the most common cancer in women (excluding skin cancer) in the United States and is the
second leading cause of cancer death in women (ACS, 2009). It is the leading cause of death in
women 35 to 50 (ACS). According to the American Cancer Society (ACS), about 1.3 million
women will be diagnosed with breast cancer worldwide and about 465,000 will die from the
disease annually. In 2009 there will be approximately 192,370 new cases of invasive breast
cancer and 40,170 deaths from breast cancer in the United States. A woman’s risk for breast
cancer to age 39 is 1 in 210, while women 40 to 59 have a 1 in 26 chance of developing breast
cancer. In West Virginia alone, there were over 1,100 new cases of breast cancer in 2008 (ACS,
2009). The site where this capstone project took place, the Edwards Comprehensive Cancer
Center (ECCC), is located in Huntington, West Virginia. It is a stand-alone cancer center that is
affiliated with Marshall University and Cabell Huntington Hospital. In 2008, 864 cases of cancer
were seen at this cancer center with breast cancer the second most commonly treated cancer at
12.7%; 21 of these cases were women under the age of 50 (ECCC, 2008).
According to the ACS (2009), there are numerous risk factors for breast cancer. Some
can be altered, such as the use of hormone replacement therapy, alcohol use, and obesity, but
some risk factors cannot be changed. Some of these risk factors include: gender, age, genetics,
family and personal history of cancer, race and ethnicity, breast tissue density, menstruation
history, history of chest radiation, diethylstilbestrol (DES) exposure, and certain breast
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conditions such as atypical ductal hyperplasia (ADH) and lobular carcinoma in situ (LCIS).
Being female is the number one risk factor, mostly because of the exposure to the hormones
estrogen and progesterone. The risk for breast cancer increases with increasing age, with 66% of
breast cancers occurring in women over the age of 55. Women who have one first degree relative
with breast cancer have twice the risk as the average woman, while having two first-degree
relatives with breast cancer increases risk by a factor of five. Approximately 5%-10% of breast
cancers are hereditary, resulting from an inherited gene mutation. For women who have a genetic
mutation, their risk for breast cancer can be as high as 85% (ACS, 2009).
With screening modalities such as mammography, magnetic resonance imaging (MRI),
and clinical breast exams, cancer may be detected in early stages, which has been shown to
reduce mortality in breast cancer (Baltzell & Wrensch, 2005). Mammography should be started
at age 40 in women who are at average risk for breast cancer; however, there are some women
who are at increased risk for breast cancer who should start screening at an earlier age (ACS,
2009).
Many women have risk factors that can increase their risk for developing breast cancer
and they can benefit from personalized recommendations based on their personal and family
history. These women may meet criteria for additional pharmacologic or surgical options that
can reduce their risk for breast cancer. These options are often not explored at a routine doctor’s
visit, not just because of a knowledge deficit on the part of the provider but also because of time
constraints (Vogel, 2003). Women at high risk may have anxiety or depression based on their
family history of breast cancer. Clinics that evaluate familial cancer risk have become much
more common, and 80% of the referrals are women with a family history of breast cancer
(Heimdal, Maelhle, & Miller, 1999). The cost effectiveness of these clinics has not been
2

established, however, early studies have found that clinics that promote early detection
contribute to the overall psychosocial wellness and health of the patient (Heimdal, et al., 1999).
Women who are at increased risk for breast cancer may experience higher levels of
anxiety, depression, or cancer worry than women who are at average or slightly increased risk
(Lindberg & Wellisch, 2001). In a study by Meiser et al. (2000), researchers found that both state
anxiety and breast cancer related anxiety were associated with an overestimation of personal
breast cancer risk. By providing these women with an accurate risk assessment, their anxiety
may be decreased, and by extension, cancer worry and depression may decrease (Meiser et al.,
2000). This can be done by using objective assessment and discussing screening options. In
addition, there are women who are at high risk for breast cancer, such as those who carry a
genetic mutation on their breast cancer (BRCA) genes. Since these women may have up to an
85% lifetime risk for breast cancer and a 27%-44% risk for ovarian cancer, they are unlikely to
overestimate their risk. According to a study by Brain et al. (2002), risk assessment in high-risk
women only confirms their belief in their risk. Although they do have decreased generalized
anxiety, they still have persistent anxiety about breast cancer, which can compromise their
quality of life.
A position in a cancer risk assessment clinic is ideal for an advanced practice nurse with
specialized training in oncology and risk evaluation. A nurse practitioner can perform risk
assessment using validated models, complete a history and physical, make recommendations
based on findings for surveillance and interventions, and educate the patient regarding her risk
(Vogel, 2003). A study by MacDonald, Sarna, Uman, Grant, and Weitzel (2006) found that
almost a third of women at increased risk for breast or ovarian cancer did not receive adequate
breast cancer screening prior to attending their risk assessment appointment, while 12% had
3

needless ovarian cancer screening. Twelve percent of the women used untested and potentially
harmful “prevention” measures, such as homeopathy or herbs. It was also noted that most of
these women did not use chemoprevention or surgical interventions to decrease their risk,
although the reasons for not doing so were unclear (MacDonald et al., 2006). Women with a
BRCA mutation also have additional considerations such as prophylactic surgery,
chemoprevention, screening MRI, and fertility issues.
As breast cancer awareness and the science of genetics have advanced, cancer risk
assessment has become an option for women at risk for breast cancer. According to the National
Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines: Breast Cancer Risk
Reduction (2011), women who are at increased risk for breast cancer should be referred for risk
reduction counseling. Individualized risk assessment is becoming increasingly important as more
screening and prevention strategies become available. There are multiple models that assess risk,
such as the Gail Model (Gail et al., 1989), the Claus Model (Claus, Risch, & Thompson, 1994),
and BRCAPRO (Parmigiani, Berry, & Aguilar, 1998), and each of these models uses different
criteria to assess risk. It is imperative that the practitioner be aware of the strengths and
limitations of each of the models, and also be aware that none of the models assesses risk with
great accuracy, with the exception of genetic testing. This is because these are mathematical
models which calculate risk over a period of time, hence the factors included in the models only
account for a small percentage of eventual breast cancer development (Baltzell & Wrensch,
2005). It is important that women who attend a high-risk clinic feel confident in their personal
risk assessment, as major lifestyle decisions may be based on the results. It is also essential that
these high risk women see a practitioner that is aware of specialized screening, pharmacologic,
and surgical recommendations for these women about which general practitioners may not be
4

familiar (Baltzell & Wrensch, 2005). Lindbergh and Wellisch (2001) noted that health care
providers play an important role in patients’ compliance with screening procedures. Therefore it
is important that a provider that is familiar with the increased screening recommendations
discuss these options with women at increased risk. Many general practitioners are unaware of
these screening recommendations or recommendations regarding genetic test results.
Genetic testing is limited because only 5%-10% of cancer is hereditary. There are ethical,
legal and social implications (ELSI) that are associated with genetic testing that may arise. These
must be addressed and the patient must understand the implications. These visits can be very
time intensive, and many physicians neither want nor have the time to devote to these visits. A
risk assessment counseling session at a nurse led, high-risk clinic may help to allay patients’
fears and increase their quality of life (Vogel, 2003). The nurse practitioner’s role in these clinics
is to examine, educate, and facilitate referrals to empower the patient to make decisions (Vogel,
2003). In response to these findings, the purpose of this capstone project is to evaluate the effect
of a nurse-run clinic for women at increased risk for breast cancer on anxiety, depression, and
cancer worry.
Theoretical Framework
The Transactional Model of Stress and Coping (TMSC) (Lazarus & Folkman, 1984) was
the theory chosen to guide the project. The TMSC is a framework for assessing how one copes
with stress inducing events. This theory takes into account both the characteristics of the person
as well as the environmental event and the relationship between the two. If the person evaluates
the situation and determines that the event exceeds his/her coping resources, then his/her wellbeing is endangered in the form of psychological stress (Lazarus & Folkman, 1984).
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In Lazarus and Folkman’s TMSC theory (1984), a person must evaluate the potential
threat or stressor, which is called the primary appraisal. There are three different categories of
primary appraisal: irrelevant, benign-positive, or stressful. An irrelevant environmental
encounter does not affect the person in any way, so there is no concern about the outcome of the
encounter. A benign-positive encounter is one in which the person assumes the outcome of the
encounter will be constructive, enhancing well-being. These encounters, although positive, may
still produce anxiety. A stressful encounter can include the belief that a stressor is currently
harmful or may cause a threat in the future. Lazarus and Folkman (1984) theorize that there are
three types of stress appraisals, harm/loss, threat, and challenge. These three appraisals are not
mutually exclusive; a stressful event can have elements of all three types.
The secondary appraisal is the person’s evaluation of his/her coping resources and the
controllability of the stressor. The secondary appraisal is the assessment of what can be done to
manage the situation. It is an intricate process whereby a person assesses his/her coping
resources, evaluates whether he/she believes these resources will work, and whether or not
he/she can apply these resources in order to combat the stressor. A person’s evaluation of
primary and secondary appraisals is complex and determines the reaction to the stressor.
Coping efforts that are employed to control the situation lead to outcomes of coping
(Lazarus & Folkman, 1984). Coping efforts can be negative or positive strategies and mediate
the primary and secondary appraisals. These coping efforts may be problem management efforts
which attempt to change the stressful situation or emotional regulation which attempts to change
how one feels about the stressor. Problem management strategies can include information
seeking or problem solving and work best for stressors that can be changed. Emotional
regulation can include: denial, avoidance, wishful thinking, self-blame, or social support, and
6

work best for stressors that cannot be changed, or when problem management strategies don’t
work. Other coping efforts can include disengaging strategies, where the person transfers
attention away from the stressor, and engaging strategies, where the person sees the stressor as
something he/she can control. Meaning-based coping encourages positive feelings and can
involve religion or spirituality (Lazarus & Folkman, 1984).
A person’s coping style is the way he/she reacts to a stressor, and is generally relatively
stable over time, as opposed to coping efforts, which are the strategies employed to deal with the
stressor. Two common types of coping styles are optimism and information seeking. Optimism is
the propensity to have a positive outlook. People who are optimistic have been shown to be
better adjusted psychologically. People who have information seeking coping style can be
vigilant, which is considered monitoring, or avoiders, which is considered blunting. Both
monitoring and blunting can have positive and negative outcomes. Coping outcomes are the
result of the person’s reaction to the stressor. The three main outcomes are emotional well-being,
functional status, and health behaviors, all of which can occur at different times (Lazarus &
Folkman, 1984).
Women who are at increased risk for breast cancer may experience higher levels of
anxiety and/or cancer worry than women who are at average or slightly increased risk. This
anxiety and cancer worry can cause depression. In a study by Meiser et al. (2000), the
researchers found that both state anxiety and breast cancer related anxiety were associated with
the overestimation of personal breast cancer risk. This demonstrates the need to use a theory that
explores emotional needs of patients.
For women who are at increased risk for breast cancer, the stressful event is their risk.
They perform a primary appraisal to ascertain if they are threatened by this risk. If they do not
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perceive this as a risk, then they do not experience significant levels of stress and do not need to
employ coping mechanisms. These women also undergo a secondary appraisal to determine if
they have the coping skills to deal with this stressor. If they do not have adequate coping
mechanisms to deal with this stressor, they may employ poor coping strategies by avoiding the
situation, causing negative stress. However, if they feel they are able to cope with this stressor,
they may use positive coping methods like information seeking (scheduling an appointment at a
high risk clinic) to positively deal with their stress. An understanding of the TMSC and coping
mechanisms of different patients will help guide the treatment of high risk patients, allowing the
practitioner to tailor the educational component of the session to best suit the patient’s needs.
Everyone reacts to stress differently. The utilization of the TMSC theory to guide the
capstone project is based on the assumption that women will attend this clinic as a coping
strategy. It is hoped that educating patients on their personal risk and screening recommendations
will decrease their personal stress. It is expected that by decreasing stress, then anxiety,
depression, and cancer worry will also be decreased.
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Chapter II
Review of the Literature
Search Strategy
The search strategy for relevant articles included searching National Guidelines
Clearinghouse, the Cochrane Library, Academic Search Complete, EBSCO host, CINAHL, and
PUBMED. No limits were set on the years, language or country, but the search was limited to
adults. Using the keyword high-risk breast clinic, the initial search yielded 695 hits. The search
was narrowed by searching the key words high, risk, breast, cancer, clinic, and anxiety, which
yielded 43 hits, 22 of which were appropriate. The search was done combining the same key
words with quality of life in place of anxiety, with 24 hits obtained, 9 of which were appropriate.
When satisfaction was substituted for quality of life, 22 hits were obtained, 4 were duplicates and
6 were appropriate. Twelve more articles were found by the use of snowballing. An updated
search was done using depression and worry with the other key words. Thirty hits were obtained
with depression and eleven with worry; all were duplicates. This was later updated to include up
to May 2011 but no additional articles appropriate to this project were found. An updated
version of the clinical practice guideline (NCCN, 2011) was added.
Inclusion Criteria
Abstracts of relevant articles were scanned to identify if the study included high or
moderate risk women and if they were seen in a clinic setting. Articles that appeared relevant
were obtained. Twenty-six articles were printed for consideration. Of these articles, 16 were
excluded because anxiety or cancer worry was not the main outcome evaluated; one article was
excluded because of unclear inclusion and exclusion criteria. Nine articles that appeared to
contain the highest level of evidence and met criteria were assessed for validity for inclusion in
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this review. A clinical practice guideline (CPG) was also added. The nine research articles and
one CPG included in this review were the strongest sources of evidence. Of the nine articles
chosen, two were systematic reviews (Sivell, Iredale, Gray, & Coles, 2007; Thewes, Meiser,
Tucker, & Schnieden, 2003), two were randomized controlled trials (Brain et al., 2002; Torrance
et al., 2006), two were cross-sectional designs (Trask et al., 2001; Loescher, 2003), two were
descriptive studies (Hopwood et al., 2004; Stacey, DeGrasse, & Johnston, 2002), and one was a
longitudinal study (Lobb et al., 2004).
Critical Appraisal
The Scottish Intercollegiate Guidelines Network (SIGN, 2008) criteria for validity were
used to evaluate the systematic reviews (Sivell et al., 2007; Thewes et al., 2003) and the
randomized controlled trials (Brain et al., 2002; Torrance et al., 2006). The cross-sectional
studies (Trask et al., 2001; Loescher, 2003), descriptive studies (Hopwood et al., 2004; Stacey et
al., 2002), and longitudinal study (Lobb et al., 2004) were assessed for validity using the
Quantitative Literature Review Worksheet (Larrabee, 2009). None of the studies had a research
question, but the objectives were clearly identified in all studies.
The NCCN clinical practice guideline: Breast Cancer Risk Reduction (2009) was
assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE) instrument to
evaluate validity (AGREE, 2001). This guideline had numerous strengths. Although there was no
specific clinical question, it was clear that the objective of the guideline was to address the care
and follow up of patients at high risk for cancer due to numerous causes. The development of the
guidelines included numerous specialists from many specialties, including oncology and
genetics, and the panels often included patient representatives. These guidelines were developed
by explicit review of the evidence by recognized experts, and treatment recommendations were
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developed through performance measurement. The methods used to formulate recommendations
were clearly described in the guidelines, and the criteria for selecting the evidence was described
on their web site. The guidelines clearly delineate who should be referred for risk assessment
counseling, and a logarithm guides risk reduction interventions. According to these guidelines,
women who have a known or suspected genetic mutation, a close relative with breast and ovarian
cancer, a close relative with breast cancer diagnosed prior to age 50 or bilateral breast cancer, a
close relative with a combination of breast cancer with specific other cancers, prior thoracic
radiation therapy, a personal history of atypical ductal hyperplasia, a personal history of lobular
carcinoma in situ, or a five year breast cancer risk greater than or equal to 1.7% or lifetime risk
greater than 20% with a life expectancy of greater than or equal to 10 years should be referred
for risk reduction counseling. Risk reducing surgeries or medications can be offered; patients
declining a more aggressive screening will need to be followed. There were a few limitations of
these guidelines. There was no pilot study, no potential organizational barriers were discussed,
and the costs of applying the recommendations were not considered (NCCN, 2009). There were
no changes to the 2011 guidelines regarding recommendations for referral for risk reduction
counseling (NCCN, 2011).
The first systematic review (Sivell et al., 2007) evaluated the impact of genetic risk
assessment services on patients who were at risk for familial breast cancer. Data searches were
conducted using MEDLINE, EMBASE, CIHAHL, PsychLIT, CENTRAL, DARE, ASSIA, Web
of Science, SIGLE, and, LILACS. All languages were included, and the search period was from
1985 to 2005. Two independent reviewers assessed all studies to determine if inclusion criteria
were met. A third person arbiter was utilized for issue resolution. The authors had clear criteria
for selecting articles, and inclusion criteria were clearly identified. Three randomized controlled
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trials from five papers were included in this review, with 1251 participants. Differences between
the papers were evaluated. A meta-analysis was not performed because of the heterogeneity of
the studies. The outcomes of interest in the review were general anxiety, breast cancer worry,
perceived risk of breast cancer, and patient satisfaction. According to the review, there is a
benefit to cancer genetic risk assessment including reduced distress, increased knowledge of
breast cancer and genetics, and improved perceived risk. Patients were generally satisfied with
services and overall found the appointment very useful. There was no evidence to suggest the
assessment caused psychological harm, however, there was no follow up for longer than nine
months. This review included a large sample size, but only three trials were included. The
authors did note that cancer genetic services had only been established for about 20 years, so
there was limited data (Sivell et al., 2009).
The second systematic review (Thewes et al., 2003) described 17 studies for risk of
psychological distress in women with a family history of breast cancer. Data searches were
rigorous and included the databases MEDLINE, PsychLIT, and EMBASE which were searched
from 1980 to 2003. The key phrases hereditary breast cancer, psychological adjustment,
psychological distress, anxiety, and depression were searched individually and in combination.
A manual search of specialty journals was also done for the years 1990 to 2003. Studies were
included if they were published in a peer reviewed journal in English, if the women had a family
history of breast cancer but no personal cancer history, if they addressed sociodemographic,
family history or distress, and included psychological and emotional outcomes as primary
outcome measures. Several studies found an association between perceived risk of developing
breast cancer and distress, anxiety, and depression. Some of these studies found associations with
psychological outcomes if risk was overestimated by more than 50%. Two of the studies found
12

an association between a parent’s death from breast cancer and distress, and two studies found
that women who had been caregivers for their mothers with breast cancer had higher distress
levels. Study results were inconsistent on several potential risk factors. One study found the
number of relatives with breast cancer was associated with distress, while another found no
association. Studies found significant associations between psychological distress and past
psychiatric history, low perceived control, poor adherence to screening, low social support, low
sexual satisfaction, low social desirability, poor understanding of general population risk, and
hereditary nature of breast cancer. Strengths of this review included a large number of studies
and multiple variables assessed, however, data was not combined because of the heterogeneity of
the studies (Thewes et al., 2003).
Two randomized controlled trials (RCT) were evaluated (Brain et al., 2002; Torrance et
al., 2006). Blinding was not possible in either study due to the nature of the trials. Treatment and
control group demographics were similar enough for comparison. The first RCT (Brain et al.,
2002) assessed the psychological impact of risk assessment on women with different risk levels.
Participants included 653 women who had a first degree female relative diagnosed with breast
cancer before age 50, a first degree female relative with bilateral breast cancer, two or more first
degree relatives with breast cancer, or a first and second degree relative with breast cancer.
Sampling was consecutive and randomly assigned by computer. A surgical staff saw the control
group, while the trial group was seen by a multidisciplinary team who conducted genetic risk
assessment and counseling. All of the participants completed baseline anxiety tools prior to
counseling. These were the State Trait Anxiety Inventory (Spielberger, 1983) and the Breast
Cancer Worry Scale (Lerman et al., 1991). They completed the same scales plus a satisfaction
survey, the Satisfaction with Genetic Counseling Questionnaire (Shiloh, Avdor, & Goodman,
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1990), after their appointment. This study found that beliefs about personal risk can be adjusted
by risk assessment. For women who were at high risk for breast cancer, risk assessment confirms
their belief that they are at increased risk. These women were less satisfied with their consult,
regardless of their study group assignment (P<0.001). Subjects did have decreased generalized
anxiety (P<0.001), but had consistent worries regarding breast cancer, which affected their
quality of life. Lower risk women had decreased anxiety and breast cancer concerns regardless of
whether or not they had genetic analysis (P<0.001). From baseline to follow up there was a
significant overall reduction in breast cancer worry (P<0.001). This trial was strengthened by its
large sample size and use of randomization; however, it was an English study, so it may not be
generalizable to US women. Also, the control group was seen by a surgical specialist group, who
may have more genetic expertise than general practice groups (Brain et al., 2002).
The second trial by Torrance et al. (2006) evaluated two concurrent RCTs at two
different sites. Results were comparable for both sites. Sampling was consecutive and patients
were randomly assigned by computer. One site had 289 participants, while the other had 297
participants. Inclusion criteria included women over 18 with a family history of breast cancer
and with the ability to speak English. Women who had a known BRCA mutation were excluded.
The control group was seen by a physician-based service, while the treatment group included an
evaluation by genetic nurse counselors. The researchers found that for an initial risk assessment
consultation, a visit with the nurse appears to be equivalent to a physician visit. Anxiety was
measured with the Spielberger (1983) State-Trait Anxiety Inventory (STAI) and the Hospital
Anxiety and Depression Scale (HADS) (Zigmund & Snaith, 1983), depression was measured by
the HADS, and patient satisfaction was measured with a modified version of the Satisfaction
with Genetic Counseling Questionnaire (Shiloh et al., 1990). A confidence interval approach was
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used for the statistics since this was an equivalence trial. The outcome differences were
calculated and adjusted for differences in baseline scores using multiple linear regressions.
Equivalence limits were set at + 4 for the STAI and 1/3 baseline standard deviation scores for the
HADS. There were small reductions in anxiety in all groups, and patient satisfaction was high in
all groups. Anxiety and depression scores were calculated and were consistent with equivalence,
meaning the 95% confidence interval for the difference between the intervention and control
group fell completely within the predetermined equivalence limit. The results of this study
suggest that for the initial visit of a genetic counseling session, nurses can provide care that is
comparable to that of physicians related to satisfaction and psychosocial issues. Strengths of this
trial included the large sample size and the use of parallel randomized trials; however, this was
also an English trial, thus possibly not generalizable to a U.S. sample. Also, the study end point
was when the patient learned her risk status, which could have major impact on her anxiety
(Torrance et al., 2006).
The remainder of the studies were evaluated using Larrabee’s (2009) Quantitative
Literature Review Worksheet (Trask et al., 2001; Loescher, 2003; Hopwood et al., 2004; Lobb,
et al., 2005). A study by Trask et al. (2001) used a cross-sectional design with a consecutive
sampling method. Participants included 290 women with a family history of breast or ovarian
cancer in one or more close relatives, or other risk factors leading to increased risk for breast or
ovarian cancer. After initial contact with the clinic, potential participants were sent the Clinic
Questionnaire (CQ), which collected demographic information, and the Worry Interface Scale
(WIS), both of which were created by the authors. Questionnaires were then evaluated and
women who had concerns that could be addressed by the clinic were offered appointments. At
the initial appointment and prior to counseling, patients completed the Profile of Mood States
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(POMS) (McNair, Lorr, & Droppleman, 1971) questionnaire and Medical Outcomes Survey
Short Form 36 (SF-36) (Ware, 1993) questionnaire. One month after the initial appointment,
participants completed the WIS a second time and returned it by mail. Approximately 2/3 of the
women felt that worrying about breast cancer interfered with their functioning, and these women
generally felt more distressed with significantly higher levels of confusion (F [1,91]=8.90;
p<0.004) and anxiety (F [1,81]=6.22; p<0.015). This study had a large sample size and used
multiple tools to assess cancer specific worry, but causality cannot be determined because of the
correlational design. The sample also lacked diversity with 70.7% of the participants being
Caucasian, 1.4% African American, and less than 1% coming each from Native American,
Hispanic, or Asian races. The remaining 26.5% were either unknown, not asked, or another race
(Trask et al., 2001).
Loescher (2003) assessed cancer worry in women with hereditary risk factors for cancer.
This study used a cross-sectional design with a convenience sample. Participants were 200
women over 18 with no personal history of breast cancer who met at least one criterion for
hereditary breast cancer risk and were recruited from a mammography facility and cancer
prevention center. They completed a Thoughts about Cancer Scale (Loescher, 2001) and
demographic questionnaire prior to their appointment. Their perceived risk of cancer was
assessed by their answer to the question “My chance of developing cancer during my life is
___%”. This study found that these women sometimes worried about developing breast cancer.
Having a breast biopsy was significantly correlated with cancer worry, and women with clinical
breast symptoms were more likely to have higher levels of breast cancer worry (X2=12.763,
df=6, p=0.047). Although this study had a large sample size, it used a newly developed survey
tool, participants lacked diversity and participants were recruited from a mammography facility
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and cancer prevention center, so their anxiety may have been decreased from previous
consultations (Loescher, 2003).
A study by Hopwood et al. (2004) assessed psychosocial outcomes of counseling services
for familial cancer. This was a descriptive study with a convenience sample of 256 women over
the age of 18 with no history of cancer. There were five centers included in this study. Results
were comparable for all sites. These centers were randomly selected from groups of centers
ranked by different levels of clinical activity. Participants completed questionnaires assessing
demographics, risk perception (a protocol specific 14 item scale), mental health (General Health
Questionnaire [Goldberg & Williams, 1988]), and health services use (modified Cancer Worry
Scale [Watson et al, 1998; Hopwood et al, 2001]). Patient satisfaction was measured at the
follow-up visit, and follow-up questionnaires were mailed at one and 12 months. The researchers
found that there were no significant differences in psychological distress between the centers at
baseline or either follow-up on psychological distress. There was also no significant difference in
cancer specific distress. At all centers there was a reduction in cancer worry scores from
baseline to one month and baseline to 12 months in participants who inaccurately estimated their
risk in either direction (P<0.001). Patient satisfaction was high at all centers. Strengths of this
study included the large sample size and the fact that it was a multi-center study where centers
were chosen randomly. However, each center had a small sample size and there was limited
information about inclusion and exclusion criteria for participants (Hopwood et al., 2004).
Another descriptive study addressed the support needs of women who were at high risk
for breast cancer (Stacey et al, 2002). This study evaluated 97 consecutively sampled women
who had a 1.66% or greater five-year risk for breast cancer, atypical ductal hyperplasia, lobular
carcinoma in situ, or a positive genetic test. A self-report questionnaire was completed prior to
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their first visit and a satisfaction survey was completed post visit. The most common information
needs noted were personal risk factors, breast cancer prevention and screening, lifestyle changes,
use of hormone replacement therapy, genetic testing, and Tamoxifen use. Women were satisfied
with the emotional support they received. Although the sample size was small, it was large
enough to detect differences. However, the tool they used was not psychometrically tested, and
the sample size was mostly well-educated Caucasian women, which may not be generalizable to
all high-risk women (Stacey et al., 2002).
A longitudinal study by Lobb et al. (2004) evaluated the differences in communication
skills of individuals and whether this affected outcomes such as anxiety, depression, and
satisfaction. This was a multi-center study with 158 consecutively sampled participants who
were at high risk and had not had genetic testing or a prior consultation. Participants completed a
breast cancer genetics knowledge questionnaire (Lerman et al, 1996), Impact of Events Scale
(Horowitz, Wilner, & Alvarez, 1979; Thewes et al, 2001), and the Hospital Anxiety and
Depression Scale (Zigmond & Snaith, 1983) at two weeks prior to their consult and four weeks
after their consult. A modified version of the Satisfaction with Genetic Counseling Scale (Shiloh
et al, 1990) was completed after the consultation. Counseling sessions were taped and
transcribed. Investigators identified that more women had their expectations met when
prophylactic surgeries were discussed (mastectomy: OR=7.34, 95% CI=1.96-27.57, P=0.003;
oophorectomy: OR=17.72, 95% CI=2.07-151.62, P=0.009). Also, discussing genetic testing
significantly reduced anxiety (t= -2.22, P=0.03) and understanding of results significantly
reduced depression (t= -1.959, P=0.052). Participants received a consultation summary letter and
this significantly reduced anxiety (OR=0.38, 95% CI=0.177-0.806, P=0.012) and significantly
increased risk perception (OR=2.61, 95% CI=1.139-6.017, P=0.023). Women whose provider
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used more supportive communication were significantly more anxious about breast cancer at the
four-week follow up (OR=1.66, 95% CI=1.25-2.19, P=0.000). The authors theorized that this
could be due to emotional concerns that were not acknowledged prior to the visit but a
significant association between increased anxiety at baseline and increased anxiety about breast
cancer was not found. This was a multi-center study with results comparable for all sites. The
sample size was also large. However, non-verbal communication was not observed because
audiotapes were used, and the sample tended to have a higher educational level than the general
population, thus the results might not be generalizable. This was also an Australian study, which
may not be generalizable to a U.S. population (Lobb et al., 2004).
Synthesis
Evidence found by critically appraising these studies indicates that there is a benefit to
specialized risk assessment. However, it is difficult to combine and analyze data because results
are heterogeneous and multiple tools were used in different studies. Current guidelines (NCCN,
2011) recommend risk reduction counseling for women at increased risk for breast cancer, and
after an extensive literature search and appraisal, all studies had data to suggest that women who
attend these clinics had decreased anxiety and increased quality of life. In one study (Brain et al.,
2002), women at extremely high risk were less satisfied with their consultation and had
persistent worries, which affected their quality of life. It has been theorized that these women
may always have anxiety. Women who have a genetic mutation such as BRCA 1 or BRCA2
have often seen many relatives develop breast cancer at a young age, and many of these family
members may have died, which can increase anxiety, cancer worry or depression (Brain et al.,
2002).
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Four of the studies lacked ethnic diversity in their samples, or participants had higher
education levels than the general population (Hopwood et al., 2004; Stacey et al., 2002; Lobb et
al., 2005; Trask et al., 2001). This makes generalizations to other populations difficult, however,
according to Lobb et al. (2005) these women are more motivated and are more likely to attend
high-risk clinics. So although the populations of these studies are not generalizable to the general
public, they are generalizable to the average population of this type of clinic.
More research is needed to determine anxiety, depression, and cancer worry levels of
women at increased risk for breast cancer, and what factors increase or decrease their stress
level. With further research, it can be determined what treatments work best for women at
increased risk. There also needs to be an inclusion of more diverse participants. Behavioral
processes can vary across ethnic and social groups, and this will need to be addressed in future
studies (Trask et al., 2001). The proposed project will address these limitations by evaluating the
effect of a nurse-run clinic for women at increased risk for breast cancer on anxiety, depression,
and cancer worry.
Congruence of Organizations Strategic Plan to the Capstone Project
The mission of the facility where the capstone project took place is to meet the lifetime
healthcare needs of those patients that the clinic serves, to provide the highest level of service,
quality and efficiency, and to advance healthcare through education. The goals of this project
were based upon this mission. The primary goal was to improve the quality of life of patients by
reducing their anxiety, depression, and cancer worry. The plan was to reduce patient’s worry,
anxiety, and depression by providing evidence based care, following practice guidelines, and
educating the patients on their risk for breast cancer.
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Project Objectives
For this project, there were four main objectives:
1.

To tailor the appointment based upon the responses of the woman to the Ways of Coping
Checklist (Folkman, Lazarus, Dunkel-Schetter, DeLongis, & Gruen, 1986).

2. To decrease symptoms of anxiety in women who were experiencing anxiety.
3. To decrease symptoms of depression in women who were experiencing depression.
4. To decrease symptoms of cancer worry in women who were experiencing cancer worry.
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Chapter III
Methodology
Evidence Based Project/Intervention Plan
This project was designed and was implemented based on evidence based guidelines. The
NCCN guidelines (2011) recommend a referral to a cancer genetics professional for risk
reduction counseling if a woman meets one or more of the criteria for familial risk assessment.
These criteria were listed earlier in this paper. This capstone project was implemented using the
TMSC to guide the development and execution of the project. This theory takes into account not
only cognitive appraisal, but also emotional issues and motivations related to health threats.
According to this theory, women who attend a high-risk clinic are exhibiting not just a health
behavior, but also a mechanism for coping with their stress (Mularczyk, Decruyenaere, Denayer,
& Evers-Kiebooms, 2007). Also, a patient’s coping mechanisms and reaction to stressors directly
influences specific health outcomes, such as performing self-breast exam or keeping
appointments for office visits or mammography. These acts are not preventative actions, but
contribute to early detection, which can cause increased anxiety based on the fear of the findings.
By learning the coping styles of patients, different educational interventions can be employed to
decrease anxiety, depression, and cancer worry (Barron, Houfek, & Foxall, 1997).
The goal of this project was to reduce anxiety, depression, and cancer worry in women at
increased risk for breast cancer through attendance at a nurse-run clinic. The plan involved
measuring these behaviors prior to being seen at the high-risk clinic. The patients underwent a
risk reduction analysis session with a nurse practitioner who has had training in risk assessment
counseling and hereditary cancer syndromes. Coping methods were assessed, and sessions were
tailored based on the results of the questionnaires. The nurse practitioner followed up with the
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patient two weeks after the initial session to answer any further questions and requested that the
patient complete the same surveys. The tools that were used included the Brief Zung Self-Rating
Depression Scale (Dugan et al., 1998), the State portion of the State Trait Anxiety Inventory
(Spielberger, 1983), Lerman’s Cancer Worry Scale (Lerman et al., 1991), and a modified version
of the Ways of Coping Questionnaire (Folkman et al., 1986). Psychometric data on these scales
is included later in this paper. It was anticipated that this project would take approximately three
to six months, and enrollment began in January 2011 and was completed in June 2011.
Procedure
New patient referrals were reviewed by the nurse practitioner for appropriateness and
were scheduled for an initial visit. Other patients already had appointments because the physician
had seen them in the past. Patients included in this study were new to the nurse practitioner.
After the patient was placed in the room by staff, the nurse practitioner discussed this study with
the patient and obtained consent if the patient was interested in enrolling. They completed the
initial forms at that time. After completion of the forms, the nurse practitioner performed the
personalized risk assessment. Their risk reduction options were discussed as appropriate. A
referral to psychiatric services was initiated if deemed appropriate by the nurse practitioner and
physician. These services were available through the cancer center where the study was taking
place. Approximately two weeks after the visit, the nurse practitioner made a follow up phone
call to the patient to see if she had any additional questions or concerns and asked her to
complete the questionnaires that were completed at the initial visit (with the exception of the
Ways of Coping Questionnaire). These forms were mailed to the patient with return envelopes
with postage included. At the completion of the study, a $5 gift card was mailed to the
participants. Thirty patients were enrolled.
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Timeline of Project Phases
The timeline for this project included three phases:
Phase one started with the development of the high-risk clinic and concluded when
institutional review board (IRB) approval was obtained. Tasks that were included in phase one
included: (a) establishing office staff and nursing support, (b) establishing administrative and
internal physician support (c) establishing external physician support (d) finding necessary tools
(e) updating literature search (f) ordering educational materials (g) preparing project for
Capstone Committee approval, and (h) preparing project for IRB approval and submission. This
phase was completed with IRB approval on January 10, 2011.
Phase two began after IRB approval and involved implementation of the capstone
project. Tasks that were included in phase two included: (a) high risk visit, which included
consent for enrollment and initial completion of tools, (b) follow up phone call and request for
test completion post visit. This phase was completed on July 1, 2011, which allowed a minimum
of two weeks for post-visit surveys to be returned.
Phase three was the evaluation phase and included: (a) analysis of the data obtained
during the capstone project (b) evaluation of the project to determine if a practice change is
necessary in the high risk clinic, and (c) dissemination of the results. This phase is currently
ongoing and will complete with the dissemination of the results of the project.
Resources
This capstone project required limited resources and many of the necessary supplies that
were needed were supplied by the capstone site. The most important resource that was needed
was support. The nurse practitioner was able to enroll 30 patients which was the goal for this
project by securing administrative and internal physician support for the project. Support from
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external physicians was limited and a strategic plan to increase outside referrals is being
considered. External physicians were sent an introductory letter regarding this clinic, and the
nurse practitioner and director of the breast center set up face-to-face meetings with key
physicians to generate support.
Instruments
The tools included: the State portion of the State Trait Anxiety Inventory (STAI)
(Spielberger, 1983), the Brief Zung Self-Rating Depression Scale (Dugan et al., 1998), and
Lerman’s Breast Cancer Worry Scale (Lerman et al., 1991). A modified version of the revised
Ways of Coping (Folkman et al., 1986) was used to assess the coping process. The STAI Form Y
(Appendix A) is a commonly used tool to measure anxiety in adults. It distinguishes between
temporary “state” anxiety, which occurs with stressful situations and resolves, and generalized or
long-term “trait” anxiety, which is personality traits and are developed in childhood. These two
types of anxiety are generally linked; usually individuals with higher trait anxiety will exhibit
higher state anxiety when faced with stressful situations (Spielberger, 1983). The STAI is a 40item instrument that utilizes a 4-point Likert scale. Statements evaluate how a person feels at that
particular moment, such as “I feel at ease” and “I feel upset”, as well as statements that assess
how the respondent feels in general, such as “I wish I could be as happy as others seem to be”
and “I am a steady person”. The STAI has good concurrent validity (up to r=0.80) and reliability
(r=0.77), as well as high internal consistency for both state anxiety (0.89) and trait anxiety (0.91),
which was replicated in a study of anxiety and compliance in women at high risk for breast
cancer (Lindberg & Wellisch, 2001). For this particular project, only state anxiety was measured
since how the respondent felt at the high-risk visit and two weeks after the visit were the
outcomes of interest.
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The BZSDS (Appendix B) measured the frequency of self-reported depression
symptoms. This tool is an 11-item instrument that was developed by Dugan et al. (1998) from
the Zung Self-Rating Depression Scale (ZSDS) (Zung, 1965). Nine questions regarding somatic
symptoms are excluded on the BZSDS that are included in the ZSDS. Some of the questions
include: “I feel downhearted, blue, and sad” and “I feel hopeful about the future”. The
feasibility, utility, and reliability of the ZSDS were studied in ambulatory cancer patients (Dugan
et al., 1998). Twenty-five oncology clinics enrolled 1109 patients. The alpha coefficients for
both scales indicated high levels of internal consistency (ZSDS: 0.84; BZSDS: 0.84). The ZSDS
and BZSDS were highly correlated (r=0.92) and the prevalence of depression symptoms was
35.9% for the ZSDS and 31.1% for the BZSDS (Dugan et al., 1998).
The Lerman Breast Cancer Worry Scale (Lerman et al., 1991) consists of three questions
(Appendix C): “How worried are you about getting breast cancer someday?” “How much does
your worry affect your mood?” and “How much does your worry affect your ability to perform
your daily activities?” The patient chooses from: not at all, rarely, sometimes, often, and almost
all the time and these choices are assigned a number value. The second and third question are
combined as worry impact, and have been found to be highly correlated (r=0.63). The first
question is considered a worry frequency variable but was also highly correlated with the other
two questions (r=0.64 and r=0.45) (Lerman, 1991). The tool also has high internal consistency
(Cronbach’s alpha=0.86) (Brain et al., 2002).
The Ways of Coping Questionnaire (Folkman et al., 1986) (Appendix D) is a 66-item
survey that has been widely used to measure coping. There is a more recent modified version
from 1988, but the 1985 version is in the public domain and does not require permission to use.
Only minor modifications were made to the 1988 version. Participants indicate the extent to
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which they use different coping skills in response to a specific stressful situation. A 4-point
Likert style format is utilized, and the patient chooses from: not used, used somewhat, used quite
a bit, and used a great deal. Answers correlate to eight different coping scales, including:
confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility,
escape-avoidance, painful problem solving, and positive reappraisal. Factor analysis was derived
from a study of 75 married couples who were interviewed monthly over five months. They were
asked to describe the most stressful situation they had encountered in the previous week, and
then complete the questionnaire based on that experience. Items were analyzed using alpha and
principal factoring. Thirty-seven items were reliable across all three analyses and loaded high
consistently (Folkman et al., 1986). Because this questionnaire was not the only form that needed
to be completed for this protocol, it was modified to reduce participant burden. Items were
chosen based on appropriateness to this population and high factor loadings. The high-risk visit
was modified based on participants’ responses to questions. For example, if a woman feels she
copes best by seeking social support, then she may benefit from attending a support group
meeting. If she copes by escape-avoidance, then it is important to emphasize the importance of
early detection and screening. Questions included can be seen in Appendix D. The Zung and
Ways of Coping tools are available free of charge and permission to use the Lerman Scale has
been obtained from Caryn Lerman by e-mail correspondence (Appendix E). Permission to use
the STAI was obtained from Mind Garden (Appendix F). The investigator calculated the
reliability of the tools with the sample.
Financial Plan/ Budget
Educational materials were received from the ACS and National Cancer Institute free of
charge. These materials did not directly pertain to the capstone project but are necessary for risk
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assessment education. The institution provided office space, staff, and supplies. The student had
access to these resources through her role as the nurse practitioner at the high-risk clinic. The
student was responsible for the cost of ordering the STAI as well as the cost of stamps for the
return envelopes. Funding was obtained from West Virginia University for a $5 gift card to be
sent to the patient at the completion of the project.
Evidence of Key Site Support
Edwards Comprehensive Cancer Center supports numerous internal research projects,
and this project had verbal support from the Cancer Center Clinical Director, the Director of the
Breast Health Center, and the Director of Research Services. See Appendix G for letters of
support.
Stakeholders
Stakeholders are those who were affected by this project. The key stakeholders for this
project were: patients and their family members, administration, staff, and physicians at ECCC,
external referring physicians, and the Capstone chair and committee members.
Planned Evaluation
The objectives of this project were evaluated to determine if it was successful.
Patient responses on the Ways of Coping Checklist (Folkman et al., 1986) were reviewed
with the patient as the first objective and incorporated into the educational appointment.
Edwards Comprehensive Cancer Center had many resources available to patients, including
psychological services and support groups, which were offered to participants free of charge.
The second objective, that women experiencing anxiety prior to the appointment would
report a decrease in anxiety after an appointment at a high risk clinic was evaluated by
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comparing baseline STAI scores to those at two weeks post visit. A paired t-test was used to
determine statistical significance with a p value of 0.05.
The third objective, that women experiencing depression prior to the appointment would
report a decrease in depression after appointment at the high risk clinic was evaluated by
comparing baseline Brief Zung Self Rating Depression Scale scores to those at two weeks post
visit. A paired t-test was used to determine statistical significance with a p value of 0.05.
The fourth objective that women experiencing cancer worry prior to the appointment
would report a decrease in cancer worry after an appointment at the high-risk clinic was
evaluated by comparing Lerman’s Cancer Worry Scale scores to those at one two weeks post
visit. A paired t-test was used to determine statistical significance with a p value of 0.05.
Tracking referrals through the medical record system assessed internal and external
physician support. Demographic information was collected as well.
Ethical Considerations
This project was approved through the Marshall University Institutional Review Board.
Enrollment was discussed with prospective patients with the understanding that participation was
voluntary and care would not be affected regardless of decision to enroll. Consent was
thoroughly discussed and time for questions was allowed.
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Chapter IV
Results
Demographics
All patients seen in the high-risk clinic were offered enrollment in this trial if they met
enrollment criteria, and they had not seen the nurse practitioner in the past. Thirty-seven women
were offered enrollment in the trial and 30 accepted. All women who met inclusion criteria were
offered enrollment. All participants completed the pre-test surveys and twenty-three participants
completed the post-visit surveys (76.7%). Eleven patients were new to the nurse practitioner and
had not been seen by the physician in the past. Six of these patients returned their post-visit
surveys. Nineteen patients were new to the nurse practitioner but had seen the physician in the
past; 17 of these patients returned their post-visit surveys. The sample (N=23) was 100% female
and 100% Caucasian. Patient visits were coded as: 1) new patient genetic visit (N=4, 17.4%), 2)
new patient high-risk visit (N=2, 8.7%), 3) genetic visit/ has seen Dr. McKinney in past (N=5,
21.7%), 4) high risk visit/ has seen Dr. McKinney in past (N=12, 52.1%). Age of participants
ranged from 30 to 82 with a mean age of 52.5. All patients were new to the nurse practitioner.
Twenty patients had a family history of breast cancer (86.9%). Three patients (13.1%) reported a
family history of both breast and ovarian cancer. Three patients (13.1%) had a personal history
of atypical ductal hyperplasia in addition to their family history. Family history was generally by
patient report with pathology reports obtained for two cases to confirm breast cancer. It is
possible that the reports of ovarian family history were either cervical or endometrial cancer as
some patients incorrectly assume a “female” cancer is an ovarian cancer.
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Coping
The first objective, to tailor the appointment based upon the responses of the woman to
the Ways of Coping Checklist was achieved. The revised Ways of Coping Questionnaire was
administered and the visit was tailored based on responses. The Ways of Coping Scale has eight
coping scales including (see Appendix D for questions): confrontive coping (#8), distancing (#3,
#13, #16), self-controlling (#4, #15, #17), seeking social support (#2, #5, #10, #14), accepting
responsibility (0), escape/avoidance (#11, #18, #19), painful problem solving (#1, #7), and
positive reappraisal (#6, #9, #12, #20). As patients can use more than one style of coping, the
responses were not mutually exclusive. Confrontive coping occurs when the patient takes
aggressive measures to change the situation, and can involve risk taking. If a patient used this
kind of coping, it was important to stress the importance of screening, and make sure they
understand the risks and limitations of screening and risk reduction modalities. If a patient
employed distancing as a coping mechanism, their personal risk and risk factors as well as the
importance of screening was stressed, as people who cope in this way may try to diminish their
risk. For those patients that used self-controlling as a coping mechanism, it was important to
provide written educational materials as they may not immediately ask questions and internalize
their feelings. Seeking social support was another coping method, and it involved seeking
tangible support, whether from friends or professionals. Simply coming to the appointment
fulfilled this method, and written and verbal educational information was given. Information was
also given regarding the support group for breast cancer. Accepting responsibility involved
taking personal responsibility for the problem. No questions were included in the modified scale
as it was not appropriate for the purpose of the study. Escape or avoidance included trying to
forget or avoid the problem, and in cases where a patient employed this, it was necessary to
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determine what techniques she used to avoid the problem. For example, if she smoked, smoking
cessation options were discussed. Planful problem solving is an analytical method of
approaching problem solving. In patients who used this mechanism, a written plan was given
and discussed. Positive reappraisal focuses on personal growth and may have a religious aspect.
Information on the facility’s counseling services and support group were given to these patients.
It is important to recognize that all patients cope differently and most people use a combination
of many of these coping skills, not just one particular type. Therefore, all patients were provided
verbal information and were offered written materials. Their personalized screening schedule or
risk assessment was also available in a paper format. The support group and counseling services
were available to all patients.
Using descriptive statistics, there were four responses in which the majority of
participants marked as “used a great deal”. These included: “I made a plan of action and
followed it”, “Talked to someone who could do something concrete about the problem”,
“Rediscovered what is important in life”, and “I prayed”.
Anxiety
The second objective, to decrease anxiety in women who were experiencing anxiety, had
marginally significant results. The state portion of the State Trait Anxiety Inventory was
administered prior to the educational session and was mailed again approximately two weeks
after the visit. The mean of the total scores (N=23) at pre-visit was 38.48 and post-visit was
35.30. Sixteen of the patients who returned their surveys (69.6%) had anxiety scores that
decreased after their visit. Using a paired t-test, results were significant at p=0.047 (95% CI;
0.047-6.308). Six patients (26%) received a score on their pre-test, which indicated they may be
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anxious. Three of these patients were on medications for anxiety from another provider prior to
the high-risk visit. All of the patients were offered a counseling visit.
Cronbach’s alpha was performed to assess reliability of this tool. Because questions are
asked in both positive and negative formats, it was necessary to reverse the scores of 10 of the
items. The alpha coefficient score was 0.957, indicating good reliability of this tool with this
sample.
Depression
The third objective, to decrease depression in patients that are experiencing depression
was not significant. The Brief Zung Self Rating Depression Scale was also administered to
participants prior to the educational session and was mailed again approximately two weeks after
the visit. The mean of the total scores (N=23) at pre-visit was 22.13 and post-visit was 21.13.
Thirteen of the patients who returned their surveys had a decrease in depression scores (56.5%);
one patient had the same score (0.04%). Using a paired t-test, results were not significant at
p=0.252 (95% CI; -0.764-2.764). Six patients (26%) received a score on their pre-test, which
indicated they were moderately depressed. Three of these patients were on medications for
depression from another provider prior to the high-risk visit. All of the patients were offered a
counseling visit.
Cronbach’s alpha was again performed to assess reliability of this tool. Because questions
are asked in both positive and negative formats, it was necessary to reverse the scores of 3 of the
items. The alpha coefficient score was 0.896, indicating good reliability of this tool with this
sample.
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Cancer Worry
The Lerman’s Breast Cancer Worry Scale was administered prior to the educational
session and was mailed again approximately two weeks after the visit. The mean of the total
scores (N=23) at pre-visit was 7.00 and post-visit was 6.96. Eleven of the patients who returned
their surveys had a decrease in cancer worry scores (47.8%); four patients had the same score
(17.4%). Using a paired t-test, results were not significant at p=0.909 (95% CI; -0.733-0.820).
Cronbach’s alpha was performed on the three questions and was 0.882, indicating good
reliability of the tool with this sample.
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Chapter V
Discussion and Recommendations
Discussion
The purpose of this project was to evaluate if anxiety, depression, and/or cancer worry
was decreased in women at increased risk for breast cancer who had any or all of these
symptoms after a visit at a high risk clinic. Their coping mechanisms were evaluated prior to the
visit as well, and the visit was tailored to best meet their educational needs.
Coping involves dealing with stressful situations, and everyone has different ways of
dealing with stress. In this sample, two of the most used coping mechanisms on the coping scale
involved gathering more information. A visit at a high-risk clinic involves personalized
information on a patient’s risk of cancer as well as education on specific conditions of the breast,
including atypical ductal hyperplasia, lobular carcinoma in situ, or family history of breast
cancer. By gathering data the patient may be better able to cope with her risk for cancer. It is
hoped that by educating the patient on their risk as well as early detection methods that any
anxiety, depression, and/or cancer worry they may have will be decreased.
There were six patients who were offered a referral to a mental health professional based
on their results on the STAI (greater than 55). Three of these patients returned their post-visit
surveys and all three STAI scores decreased. If patients had a score of 33 or above on the
BZSDS, they were offered a consultation with our psychiatric services. The BZSDS categorizes
scores into normal (11-21), mild (22-32), moderate (33-38), or severe (39-44) ranges for
depression. The same six patients who had increased anxiety scores also scored 33 or above (34
was the highest score) on the pre-survey and no patients scored 33 or above on the post.
However, only three returned their post-visit surveys.
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Six patients were offered referrals to a mental health professional based on their STAI
and BZSDS scores. Five patients declined a visit with the psychologist; two of these were
already under the care of mental health professionals. One agreed to the visit, but never returned
calls to the psychologist. It is possible that at least some of these patients that had anxiety
and/or depression unrelated to their risk for cancer, especially the two that were already under
the care of a mental health specialist. It is very difficult to ascertain if the anxiety and/or
depression is due to risk for cancer or other factors.
Although mean anxiety and depression scores decreased, the decrease was significant
only for anxiety. The cancer worry scale scores only had a very slight decrease in means and
were not significant. There may be a few reasons for this. First, over half of the patients enrolled
had seen a fellowship trained breast surgeon at a previous visit. Their personal risk and screening
recommendations had likely been discussed at prior visits, which may have decreased their
anxiety, depression, and/or cancer worry, which has been the case in other studies (Loescher,
2003; Brain et al., 2002). There were 11 patients that were completely new to the nurse
practitioner, but of these 11, only five completed the post-visit surveys, so the sample size was
too small to produce meaningful results. Secondly, although both the STAI and BZSDS are well
validated in the oncology setting, there is limited information on the use of these tools in women
who are at increased risk for breast cancer but unaffected with the disease itself. More research is
needed in high-risk clinics and hereditary assessment in the oncology realm to identify tools that
are appropriate in this setting.
There were a few limitations to this study. The main limitation is the small sample size.
All patients who met criteria were offered enrollment and only seven patients declined. There
were few new referrals to the high-risk clinic and the reasons for this are going to be explored
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further at the ECCC. The majority of the patients seen for genetic counseling had a personal
history of cancer, thus were excluded from this study. Given a longer time period for enrollment,
more results might have reached significance. There also may have been more diverse
participation if the enrollment period were longer.
A second limitation is that the patients’ feelings regarding their personal risk were not
recorded. It’s possible that the patients enrolled had a realistic view of what their actual risk was,
so their anxiety, depression, and/or cancer worry may not have decreased after the visit. Four of
the patients had BRCA testing but only two of them completed their post-visit surveys. Neither
patient had her results prior to completing the post-visit surveys, which could have affected their
results. Two of the patients had known mutations in their family so single site testing was
performed and both tested negative, making their results a true negative. Their risk of having the
deleterious mutation was 50%, so their anxiety, depression, and/or cancer worry may have been
much higher than those whose family histories were not as compelling. However, only one of
them completed her surveys and this was prior to receiving results.
A third limitation of this project was the study design. A convenience-sampling format
was used, there was no control group, and there was no randomization. By using a different
design, rigor may have been increased.
Recommendations
The NCCN guidelines (2011) recommend risk assessment as well as an increased
screening regimen for those who meet criteria. Although results were only significant for
anxiety, these measures should still be assessed at clinic visits for women who are at increased
risk for breast cancer, even if it is not by formal survey. An action plan is being discussed to
increase outside referrals to the high-risk clinic, which would increase the patient pool for further
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research. If further research is conducted, a larger sample size should be considered. The
question “My risk of breast cancer is __________%” should be asked prior to the visit as well as
after the visit so the researcher can determine if the patient has an accurate view of her risk.
Different tools to measure anxiety and depression could be considered as well. Women who are
BRCA mutation positive are at much higher risk, and this would be an excellent population in
which to study anxiety and cancer worry, but this population is very small. A recommendation
for a practice change that is being considered is sending a patient a summary letter after their
initial visit, outlining their risk and a personalized screening schedule.
In summary, there is a recommendation for possible practice changes at ECCC.
Continuing to measure anxiety, depression, and cancer worry should be considered, even if not
by formal survey. The patients coping skills and emotional state should be evaluated at each visit
and referrals to appropriate ancillary personnel should be made as needed. A summary letter of
the patient’s personal risk should be sent after the initial visit. Keeping abreast of the literature
for new evidence based recommendations should be done intermittently for new research on this
topic.
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Appendix A
Mind Garden allows for the reproduction of five sample items to be included in a proposal
(Appendix F).

-I feel calm.
-I feel secure.
-I am tense.
-I feel strained.
-I feel at ease.
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Appendix B
Zung Self Rating Depression Scale
Please mark (X) the box that best corresponds to how often you have felt that way
during the past week.

None or a
Little of
the Time

Some
of the
Time

Good
Part of
the Time

Most or
All of the
Time

1. I feel downhearted, blue, and sad

1

2

3

4

2. I enjoy looking at, talking to, and
being with attractive men/women
3. My mind is as clear as it used to be

4

3

2

1

4

3

2

1

4. I find it easy to do the things I used to
do
5. I feel hopeful about the future
used to do
6. I am more irritable than usual

4

3

2

1

4

3

2

1

1

2

3

4

7. I find it easy to make decisions

4

3

2

1

8. I feel that I am useful and needed

4

3

2

1

9. My life is pretty full

4

3

2

1

10. I feel that others would be better off
if I were dead
11. I still enjoy things I used to
off if I were dead

1

2

3

4

4

3

2

1
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Appendix C
Lerman’s Breast Cancer Worry Scale
Worry Frequency
1. How worried are you about getting breast cancer someday?
1 = not at all; 2 = rarely; 3 = sometimes; 4 = often; 5 = almost all the time
Worry Impact
2. How much does your worry affect your mood?
1 = not at all; 2 = a little; 3 = somewhat; 4 = a lot
3. How much does your worry affect your ability to perform your daily activities?
1 = not at all; 2 = a little; 3 = somewhat; 4 = a lot
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Appendix D
Ways of Coping Scale (Revised for use in the Capstone Project “An Evaluation of the Effect of a
Nurse-Run Clinic for Women at Increased Risk for Breast Cancer on Anxiety, Depression, and
Cancer Worry”
1. Just concentrated on what I had to do next- the next step.
2. Talked to someone to find out more about the situation.
3. Went on as if nothing had happened.
4. I tried to keep my feelings to myself.
5. I got professional help.
6. Changed or grew as a person in a good way.
7. I made a plan of action and followed it.
8. I let my feelings out somehow.
9. I came out of the experience better than when I went in.
10. Talked to someone who could do something concrete about the problem.
11. Tried to make myself feel better by eating, drinking, smoking, using drugs or medication,
etc.
12. Rediscovered what is important in life.
13. Didn’t let it get to me; refused to think too much about it.
14. I asked a relative or friend I respected for advice.
15. Kept others from knowing how bad thing were.
16. Made light of the situation; refused to get too serious about it.
17. I tried to keep my feelings from interfering with things too much.
18. Wished that the situation would go away or somehow be over with.
19. Had fantasies or wishes about how things may turn out.
20. I prayed.
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Appendix E
Permission to use Lerman Scale

No problem. Good luck
Caryn Lerman PhD
Mary W Calkins Professor
Department of Psychiatry and
Annenberg School
Deputy Director
Abramson Cancer Center
On Mar 28, 2010, at 1:13 PM, "Lisa Muto" <Lisa.Muto@chhi.org> wrote:

Dr. Lerman,
I am a WVU Doctor of Nursing Practice student in Huntington, West Virginia at the Edwards Comprehensive
Cancer Center. I am a women’s health nurse practitioner, and I run our Hereditary Cancer Risk Assessment
Program, counseling patients on hereditary cancer syndromes. We have recently started a program for women at
increased risk for breast cancer, and I will be seeing women in this clinic. For my capstone project, I will be
measuring anxiety and depression in women at increased risk for breast cancer. I would like to determine if their
anxiety and depression are decreased and quality of life is increased if they attend a nurse led high-risk clinic. I am
planning on using the Zung anxiety and depression scales, and would also like to use your "Breast Cancer Worry
Scale" with your permission. Please feel free to contact me with any questions. My e-mail address is
lisa.muto@chhi.org and my phone number is (304)399-6572. Thank you for your assistance.
Thank you,
Lisa Muto
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!!!"#$%&'()&*%"+,#To whom it may concern,
This letter is to grant permission for the above named person to use the following
copyright material;
Instrument: State-Trait Anxiety Inventory for Adults
Authors: Charles D. Spielberger, in collaboration with R.L. Gorsuch, G.A. Jacobs,
R. Lushene, and P.R. Vagg
Copyright: 1968, 1977 by Charles D. Spielberger
for his/her thesis research.
Five sample items from this instrument may be reproduced for inclusion in a proposal,
thesis, or dissertation.
The entire instrument may not be included or reproduced at any time in any other
published material.
Sincerely,
Robert Most
Mind Garden, Inc.
www.mindgarden.com

STAIB-AD, © 1983 Consulting Psychologists Press, Inc. All Rights Reserved.
Published by Mind Garden, Inc., www.mindgarden.com
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Letters of Support
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John H.
Hagen

Digitally signed by John H. Hagen
DN: cn=John H. Hagen, o=West
Virginia University Libraries,
ou=Acquisitions Department,
email=John.Hagen@mail.wvu.edu,
c=US
Date: 2011.07.26 12:22:15 -04'00'

